Selected research
Industry Growth & Trends
Global Exosome Analytical Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Exosome Analytical Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Exosome Analytical Service market include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Exosome Diagnostics, Beijing Enze Kangtai Biotechnology, System Biosciences, Qiagen and Norgen Biotek Corp., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Exosome Analytical Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Exosome Analytical Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exosome Analytical Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exosome Analytical Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Exosome Analytical Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Exosome Analytical Service Market by Company
Codiak Biosciences
Aethlon Medical
NanoSomix
Aruna Bio
Exosome Diagnostics
Beijing Enze Kangtai Biotechnology
System Biosciences
Qiagen
Norgen Biotek Corp.
HansaBioMed Life Sciences
AMS Biotechnology
Sistemic Scotland
NanoView Biosciences
Malvern Panalytical
Evomic Science
BioIVT
Codiak Biosciences
Creative Biolabs
Evox Therapeutics
Precision NanoSystems
Unisensor SA
VolitionRx Limited
Capricor Therapeutics
Pure Biologics
Janssen Biotech
Exosome Analytical Service Segment by Type
Exosome Isolation and Purification
Exosome Quantification
Exosome Characterization
Exosome Cargo Analysis
Exosome Uptake and Signaling Analysis
Exosome Functional Studies
Exosome Analytical Service Segment by Application
Biopharmaceutical R&D
Clinical Medicine
Life Science Research
Agricultural Technology
Other
Exosome Analytical Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Analytical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Analytical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Analytical Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Exosome Analytical Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Exosome Isolation and Purification
- Exosome Quantification
- Exosome Characterization
- Exosome Cargo Analysis
- Exosome Uptake and Signaling Analysis
- Exosome Functional Studies
Applications
- Biopharmaceutical R&D
- Clinical Medicine
- Life Science Research
- Agricultural Technology
- Other
Companies covered
- Codiak Biosciences
- Aethlon Medical
- NanoSomix
- Aruna Bio
- Exosome Diagnostics
- Beijing Enze Kangtai Biotechnology
- System Biosciences
- Qiagen
- Norgen Biotek Corp.
- HansaBioMed Life Sciences
- AMS Biotechnology
- Sistemic Scotland
- NanoView Biosciences
- Malvern Panalytical
- Evomic Science
- BioIVT
- Codiak Biosciences
- Creative Biolabs
- Evox Therapeutics
- Precision NanoSystems
- Unisensor SA
- VolitionRx Limited
- Capricor Therapeutics
- Pure Biologics
- Janssen Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Exosome Analytical Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Exosome Analytical Service Market Size by Region (2021-2032)
- 1.4.1 Global Exosome Analytical Service Market Size by Region (2021-2026)
- 1.4.2 Global Exosome Analytical Service Market Size by Region (2027-2032)
- 1.5 Key Regions Exosome Analytical Service Market Size (2021-2032)
- 1.5.1 North America Exosome Analytical Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Exosome Analytical Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Exosome Analytical Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Exosome Analytical Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Exosome Analytical Service Market Size Growth Rate (2021-2032)
2 Exosome Analytical Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Exosome Isolation and Purification
- 2.1.2 Exosome Quantification
- 2.1.3 Exosome Characterization
- 2.1.4 Exosome Cargo Analysis
- 2.1.5 Exosome Uptake and Signaling Analysis
- 2.1.6 Exosome Functional Studies
- 2.2 Global Exosome Analytical Service Market Size by Type
- 2.2.1 Global Exosome Analytical Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Exosome Analytical Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Exosome Analytical Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Exosome Analytical Service Market Size by Regions
- 2.3.1 North America Exosome Analytical Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Exosome Analytical Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Exosome Analytical Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Exosome Analytical Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Exosome Analytical Service Market Size Breakdown by Type (2021-2026)
3 Exosome Analytical Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceutical R&D
- 3.1.2 Clinical Medicine
- 3.1.3 Life Science Research
- 3.1.4 Agricultural Technology
- 3.1.5 Other
- 3.2 Global Exosome Analytical Service Market Size by Application
- 3.2.1 Global Exosome Analytical Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Exosome Analytical Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Exosome Analytical Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Exosome Analytical Service Market Size by Regions
- 3.3.1 North America Exosome Analytical Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Exosome Analytical Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Exosome Analytical Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Exosome Analytical Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Exosome Analytical Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Exosome Analytical Service Industry Trends
- 4.2 Exosome Analytical Service Industry Drivers
- 4.3 Exosome Analytical Service Industry Opportunities and Challenges
- 4.4 Exosome Analytical Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Exosome Analytical Service Revenue (2021-2026)
- 5.2 Global Exosome Analytical Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Exosome Analytical Service Key Company Headquarters & Area Served
- 5.4 Global Exosome Analytical Service Company, Product Type & Application
- 5.5 Global Exosome Analytical Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Exosome Analytical Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Exosome Analytical Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Exosome Analytical Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Codiak Biosciences
- 6.1.1 Codiak Biosciences Company Information
- 6.1.2 Codiak Biosciences Business Overview
- 6.1.3 Codiak Biosciences Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 6.1.5 Codiak Biosciences Recent Developments
- 6.2 Aethlon Medical
- 6.2.1 Aethlon Medical Company Information
- 6.2.2 Aethlon Medical Business Overview
- 6.2.3 Aethlon Medical Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aethlon Medical Exosome Analytical Service Product Portfolio
- 6.2.5 Aethlon Medical Recent Developments
- 6.3 NanoSomix
- 6.3.1 NanoSomix Company Information
- 6.3.2 NanoSomix Business Overview
- 6.3.3 NanoSomix Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 NanoSomix Exosome Analytical Service Product Portfolio
- 6.3.5 NanoSomix Recent Developments
- 6.4 Aruna Bio
- 6.4.1 Aruna Bio Company Information
- 6.4.2 Aruna Bio Business Overview
- 6.4.3 Aruna Bio Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Aruna Bio Exosome Analytical Service Product Portfolio
- 6.4.5 Aruna Bio Recent Developments
- 6.5 Exosome Diagnostics
- 6.5.1 Exosome Diagnostics Company Information
- 6.5.2 Exosome Diagnostics Business Overview
- 6.5.3 Exosome Diagnostics Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Exosome Diagnostics Exosome Analytical Service Product Portfolio
- 6.5.5 Exosome Diagnostics Recent Developments
- 6.6 Beijing Enze Kangtai Biotechnology
- 6.6.1 Beijing Enze Kangtai Biotechnology Company Information
- 6.6.2 Beijing Enze Kangtai Biotechnology Business Overview
- 6.6.3 Beijing Enze Kangtai Biotechnology Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Beijing Enze Kangtai Biotechnology Exosome Analytical Service Product Portfolio
- 6.6.5 Beijing Enze Kangtai Biotechnology Recent Developments
- 6.7 System Biosciences
- 6.7.1 System Biosciences Company Information
- 6.7.2 System Biosciences Business Overview
- 6.7.3 System Biosciences Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 System Biosciences Exosome Analytical Service Product Portfolio
- 6.7.5 System Biosciences Recent Developments
- 6.8 Qiagen
- 6.8.1 Qiagen Company Information
- 6.8.2 Qiagen Business Overview
- 6.8.3 Qiagen Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Qiagen Exosome Analytical Service Product Portfolio
- 6.8.5 Qiagen Recent Developments
- 6.9 Norgen Biotek Corp.
- 6.9.1 Norgen Biotek Corp. Company Information
- 6.9.2 Norgen Biotek Corp. Business Overview
- 6.9.3 Norgen Biotek Corp. Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Norgen Biotek Corp. Exosome Analytical Service Product Portfolio
- 6.9.5 Norgen Biotek Corp. Recent Developments
- 6.10 HansaBioMed Life Sciences
- 6.10.1 HansaBioMed Life Sciences Company Information
- 6.10.2 HansaBioMed Life Sciences Business Overview
- 6.10.3 HansaBioMed Life Sciences Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 HansaBioMed Life Sciences Exosome Analytical Service Product Portfolio
- 6.10.5 HansaBioMed Life Sciences Recent Developments
- 6.11 AMS Biotechnology
- 6.11.1 AMS Biotechnology Company Information
- 6.11.2 AMS Biotechnology Business Overview
- 6.11.3 AMS Biotechnology Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AMS Biotechnology Exosome Analytical Service Product Portfolio
- 6.11.5 AMS Biotechnology Recent Developments
- 6.12 Sistemic Scotland
- 6.12.1 Sistemic Scotland Company Information
- 6.12.2 Sistemic Scotland Business Overview
- 6.12.3 Sistemic Scotland Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Sistemic Scotland Exosome Analytical Service Product Portfolio
- 6.12.5 Sistemic Scotland Recent Developments
- 6.13 NanoView Biosciences
- 6.13.1 NanoView Biosciences Company Information
- 6.13.2 NanoView Biosciences Business Overview
- 6.13.3 NanoView Biosciences Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 NanoView Biosciences Exosome Analytical Service Product Portfolio
- 6.13.5 NanoView Biosciences Recent Developments
- 6.14 Malvern Panalytical
- 6.14.1 Malvern Panalytical Company Information
- 6.14.2 Malvern Panalytical Business Overview
- 6.14.3 Malvern Panalytical Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Malvern Panalytical Exosome Analytical Service Product Portfolio
- 6.14.5 Malvern Panalytical Recent Developments
- 6.15 Evomic Science
- 6.15.1 Evomic Science Company Information
- 6.15.2 Evomic Science Business Overview
- 6.15.3 Evomic Science Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Evomic Science Exosome Analytical Service Product Portfolio
- 6.15.5 Evomic Science Recent Developments
- 6.16 BioIVT
- 6.16.1 BioIVT Company Information
- 6.16.2 BioIVT Business Overview
- 6.16.3 BioIVT Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BioIVT Exosome Analytical Service Product Portfolio
- 6.16.5 BioIVT Recent Developments
- 6.17 Codiak Biosciences
- 6.17.1 Codiak Biosciences Company Information
- 6.17.2 Codiak Biosciences Business Overview
- 6.17.3 Codiak Biosciences Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 6.17.5 Codiak Biosciences Recent Developments
- 6.18 Creative Biolabs
- 6.18.1 Creative Biolabs Company Information
- 6.18.2 Creative Biolabs Business Overview
- 6.18.3 Creative Biolabs Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Creative Biolabs Exosome Analytical Service Product Portfolio
- 6.18.5 Creative Biolabs Recent Developments
- 6.19 Evox Therapeutics
- 6.19.1 Evox Therapeutics Company Information
- 6.19.2 Evox Therapeutics Business Overview
- 6.19.3 Evox Therapeutics Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Evox Therapeutics Exosome Analytical Service Product Portfolio
- 6.19.5 Evox Therapeutics Recent Developments
- 6.20 Precision NanoSystems
- 6.20.1 Precision NanoSystems Company Information
- 6.20.2 Precision NanoSystems Business Overview
- 6.20.3 Precision NanoSystems Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Precision NanoSystems Exosome Analytical Service Product Portfolio
- 6.20.5 Precision NanoSystems Recent Developments
- 6.21 Unisensor SA
- 6.21.1 Unisensor SA Company Information
- 6.21.2 Unisensor SA Business Overview
- 6.21.3 Unisensor SA Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Unisensor SA Exosome Analytical Service Product Portfolio
- 6.21.5 Unisensor SA Recent Developments
- 6.22 VolitionRx Limited
- 6.22.1 VolitionRx Limited Company Information
- 6.22.2 VolitionRx Limited Business Overview
- 6.22.3 VolitionRx Limited Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 VolitionRx Limited Exosome Analytical Service Product Portfolio
- 6.22.5 VolitionRx Limited Recent Developments
- 6.23 Capricor Therapeutics
- 6.23.1 Capricor Therapeutics Company Information
- 6.23.2 Capricor Therapeutics Business Overview
- 6.23.3 Capricor Therapeutics Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Capricor Therapeutics Exosome Analytical Service Product Portfolio
- 6.23.5 Capricor Therapeutics Recent Developments
- 6.24 Pure Biologics
- 6.24.1 Pure Biologics Company Information
- 6.24.2 Pure Biologics Business Overview
- 6.24.3 Pure Biologics Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Pure Biologics Exosome Analytical Service Product Portfolio
- 6.24.5 Pure Biologics Recent Developments
- 6.25 Janssen Biotech
- 6.25.1 Janssen Biotech Company Information
- 6.25.2 Janssen Biotech Business Overview
- 6.25.3 Janssen Biotech Exosome Analytical Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Janssen Biotech Exosome Analytical Service Product Portfolio
- 6.25.5 Janssen Biotech Recent Developments
7 North America
- 7.1 North America Exosome Analytical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Exosome Analytical Service Market Size by Country (2021-2026)
- 7.3 North America Exosome Analytical Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Exosome Analytical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Exosome Analytical Service Market Size by Country (2021-2026)
- 8.3 Europe Exosome Analytical Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Analytical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Exosome Analytical Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Exosome Analytical Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Exosome Analytical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Exosome Analytical Service Market Size by Country (2021-2026)
- 10.3 South America Exosome Analytical Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Analytical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Exosome Analytical Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Exosome Analytical Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst